C07K 14/003
Peptide-nucleic acids
Official title: {Peptide-nucleic acids (PNAs)}
C07K14/003 (Peptide-nucleic acids) appears on 262 US grants and 299 published applications in this corpus.
Search patents in C07K- Granted patents
- 262
- Published applications
- 299
- Assignees
- 172
- Inventors
- 558
- Latest grant
- 12 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 3 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 6 | 0 |
| 1997 | 7 | 0 |
| 1998 | 14 | 0 |
| 1999 | 10 | 0 |
| 2000 | 12 | 0 |
| 2001 | 17 | 3 |
| 2002 | 15 | 18 |
| 2003 | 14 | 17 |
| 2004 | 15 | 21 |
| 2005 | 7 | 10 |
| 2006 | 11 | 8 |
| 2007 | 2 | 8 |
| 2008 | 4 | 7 |
| 2009 | 5 | 7 |
| 2010 | 4 | 14 |
| 2011 | 6 | 6 |
| 2012 | 5 | 9 |
| 2013 | 3 | 8 |
| 2014 | 8 | 10 |
| 2015 | 7 | 5 |
| 2016 | 4 | 9 |
| 2017 | 3 | 8 |
| 2018 | 7 | 14 |
| 2019 | 13 | 27 |
| 2020 | 11 | 18 |
| 2021 | 10 | 20 |
| 2022 | 9 | 11 |
| 2023 | 9 | 16 |
| 2024 | 7 | 12 |
| 2025 | 9 | 9 |
| 2026 | 2 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Exon skipping by peptide nucleic acid derivatives12 May 2026US 12,624,068 B2OliPass Corporation
- Methods and compositions comprising therapeutic gamma peptide nucleic acid-based molecules6 Jan 2026US 12,516,087 B2University of Connecticut
- Peptide-nucleic acid complex23 Sep 2025US 12,421,627 B2Kawasaki Institute of Industrial Promotion
- Chimeric polypeptides and uses thereof2 Sep 2025US 12,404,305 B2Kite Pharma, Inc.
- Optically verified polymer synthesis26 Aug 2025US 12,398,174 B2The Charles Stark Draper Laboratory, Inc.
- Synthetic triplex peptide nucleic acid-based inhibitors for cancer therapy7 May 2026US 2026/0125428 A1University of Connecticut
- Synthetic triplex peptide nucleic acid-based inhibitors for cancer therapy2 Apr 2026US 2026/0092085 A1Beth Israel Deaconess Medical Center, Inc.
- Nucleic acid-polypeptide compositions and methods of inducing exon skipping5 Mar 2026US 2026/0060996 A1Avidity Biosciences, Inc.
- Separation and isolation of nucleic acids using affinity ligands bound to a solid surface12 Feb 2026US 2026/0042797 A1emp Biotech GmbH
- Composition containing hotspot-derived peptide-nucleic acid hybrid molecule for treating infection caused by mutated coronavirus11 Dec 2025US 2025/0376490 A1
Most cited
By later US patents
- Uncharged morpholino-based polymers having achiral intersubunit linkages1,700US 5,034,506 AAnti-Gene Development Group · 1991
- Alpha-morpholino ribonucleoside derivatives and polymers thereof900US 5,235,033 AAnti-Gene Development Group · 1993
- Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages851US 5,185,444 AAnti-Gene Deveopment Group · 1993
- Peptide nucleic acids763US 5,539,082 A1996
- Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility543US 5,714,331 A1998